Hypercalcaemia in a patient with a gastrointestinal stromal tumour.
Beckers
M M J
MM
Slee
P H Th J
PH
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D046152:Gastrointestinal Stromal Tumors / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D000068877:Imatinib Mesylate; D008875:Middle Aged; D000077268:Pamidronate; D010534:Peritoneal Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D010879:Piperazines / Q000627:therapeutic use; D019009:Proto-Oncogene Proteins c-kit / Q000378:metabolism; D011743:Pyrimidines / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001549:Benzamides; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D019009:Proto-Oncogene Proteins c-kit; D000077268:Pamidronate